Presence of HPV in head and neck tumours: High prevalence in tonsillar localization

Journal of Experimental and Clinical Cancer Research

Volumn 23, Issue 4, 2004, Pages 561-566

  Venuti, Aldo ^a   Badaracco, G ^a   Rizzo, C ^a   Mafera, B ^a,b   Rahimi, S ^b   Vigili, M ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Head and neck tumour; HPV; Prognosis; Risk factor; Tonsil

Indexed keywords

VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; CORRELATION ANALYSIS; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TOBACCO; TONSIL; TUMOR LOCALIZATION; VIRUS IDENTIFICATION; VIRUS TRANSCRIPTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, SQUAMOUS CELL; DNA; DNA PRIMERS; DNA, VIRAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TONSIL; TONSILLAR NEOPLASMS; TUMOR VIRUS INFECTIONS;

EID: 12544259905     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ferlay J., Bray F., Pisani P., Parkin D.M.: Globocan 2000: cancer incidence, mortality and prevalence worldwide. Version 1. International Agency for Research on Cancer (IARC). Cancer base No. 5. Lyon (France); IARC Press; 2001.
2. Franceschi S., Bidoli E., Herrero R., Munoz N.: Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol. 36: 106-115, 2000.
3. Herrero R.: Chapter 7: Human Papillomavirus and Cancer of the Upper Aerodigestive Tract. J. Natl. Cancer Inst. Monographs 31: 47-51, 2003.
4. Herrero R., Castellsague X., Pawlita M., Lissowska J., Kee F., Balaram P., Rajkumar T., Sridhar H., Rose B., Pintos J., Fernandez L., Idris A., Sanchez M.J., Nieto A., Talamini R., Tavani A., Bosch F.X., Reidel U., Snijders P.J., Meijer C.J., Viscidi R., Munoz N., Franceschi S.: IARC Multicenter Oral Cancer Study Group. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 95: 1772-1783, 2003.
5. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., Shah K.V., Sidransky D.: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92: 709-720, 2000.
6. Badaracco G., Venuti A., Morello R., Muller A., Marcante M.L.: Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res. 20: 1301-1306, 2000.
7. van Houten V.M., Snijders P.J., van den Brekel M.W., Kummer J.A., Meijer C.J., van Leeuwen B., et al.: Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int. J. Cancer 93: 232-235, 2001.
8. Wiest T., Schwartz E., Enders C., Flechtenmacher C., Bosch F.X.: Involvement of intact HPV 16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21: 1510-1517, 2002.
9. Manos M.M., Ting Y., Wrigth O.K., Lewis A.I., Broker T.R., Wolinsky S.M.: Use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells 7: 209-214, 1989.
10. de Roda Husman A.M., Walboomers J.M., van den Brule A.J., Meijer C.J., Snijders P.J.: The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Virol. 76: 1057-1062, 1995.
11. Biswas C., Kell B., Mant C., Jewers R.J., Cason J., Muir P., Raju K.S., Best J.M.: Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology. J. Clin. Microbiol. 35: 1560-1564, 1997.
12. Venuti A., Manni V., Morello R., De Marco F., Marzetti F., Marcante M.L.: Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J. Med. Virol. 60: 396-402, 2000.
13. Hafkamp H.C., Manni J.J., Speel E.J.: Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol. 124: 520-526, 2004.
14. Klussmann J.P., Weissenborn S.J., Wieland U., Dries V., Eckel H.E., Pfister H.J., Fuchs P.G.: Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med. Microbiol. Immunol. 192: 129-132, 2003.
15. Shah K.V.: Do human papillomavirus infections cause oral cancer? J. Natl. Cancer Inst. 90: 1585-1586, 1998.